Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01019369Not ApplicableCompleted

Study of Self or Clinic Administration of DepoProvera

Role: collaborator

NCT01356927Completed

Same-day Long-acting Reversible Contraception for Medication Abortion

Role: collaborator

NCT01013363Not ApplicableCompleted

The Use of Music for Pain and Anxiety Control During Abortion

Role: collaborator

All 3 trials loaded